Article Text

Genesis of myocardial repair with cardiac progenitor cells and tissue engineering
  1. Eugene K W Sim1,
  2. Husnain Kh Haider2,
  3. Nermine Lila3,
  4. Olivier Schussler3,
  5. Juan C Chachques3,
  6. Lei Ye4
  1. 1Gleneagles JPMC Cardiac Centre, Brunei Darussalam & Mount Elizabeth Medical Centre, Singapore
  2. 2Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio, USA
  3. 3Laboratory of Biosurgical Research, Alain Carpentier Foundation, European Hospital Georges Pompidou, University Paris Descartes, Paris, France
  4. 4Cardiovascular Research Institute, Department of Medicine, National University of Singapore, Singapore
  1. Correspondence to Dr Eugene K W Sim, Gleneagles JPMC Cardiac Centre, Brunei Darussalam, Mount Elizabeth Medical Centre, Singapore; dr.eugene.sim{at}
  2. Dr Lei Ye, Cardiovascular Research Institute, Department of Medicine, National University of Singapore, B1-12, CRC, MD11, 10 Medical Drive, 117597, Singapore; lei_ye{at}


Background There is mounting evidence to suggest that the heart has regenerative potential in the event of myocardial injury. Recent studies have shown that a resident population of cardiac progenitor cells (CPCs) in the heart contains both vasculogenic and myogenic lineages. CPCs are able to migrate to the site of injury in the heart for participation in the healing process. The resident CPCs in the heart may also be activated through outside pharmacological intervention to promote their participation in the intrinsic repair process. In the light of these characteristics, CPCs provide a logical source for the heart cell therapy. During the regenerative cardiac process, stem cell niches (a specialised environment surrounding stem cells) provide crucial support needed for their maintenance.

Discussion Compromised niche function may lead to the selection of stem cells that no longer depend on self-renewal factors produced by its environment. The objective of stem cell transplantation associated with tissue-engineered approaches is to create a new modality in the treatment of heart failure. The use of efficient scaffolds will aid to re-establish a favourable microenvironment for stem cell survival, multiplication, differentiation and function. Cardiac tissue engineering using natural and/or synthetic materials in this regard provides a novel possibility in cardiovascular therapeutics.

  • Cardiac progenitor cell
  • c-kit
  • angiogenesis
  • myogenesis
  • cardiac repair
  • tissue engineering
  • tissue characters

Statistics from


  • Competing interests None.

  • Provenance and peer review Commissioned; not externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.